<HTML>
<HEAD>
<TITLE> Prepared by MERRILL CORPORATION www.edgaradvantage.com
</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<FONT SIZE=3 ><A HREF="#00CHI3651_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<P ALIGN="CENTER"><FONT SIZE=2><B>As filed with the Securities and Exchange Commission on July&nbsp;31, 2000  </B></FONT></P>

<P ALIGN="RIGHT"><FONT SIZE=2><B> Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<HR NOSHADE>
<HR NOSHADE>
<P ALIGN="CENTER"><FONT SIZE=5><B>SECURITIES AND EXCHANGE COMMISSION  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>Washington, D.C. 20549  </B></FONT></P>

<HR NOSHADE WIDTH="120">
<P ALIGN="CENTER"><FONT SIZE=5><B>FORM S-8  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>REGISTRATION STATEMENT  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B> UNDER  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B> THE SECURITIES ACT OF 1933  </B></FONT></P>

<HR NOSHADE WIDTH="120">
<P ALIGN="CENTER"><FONT SIZE=5><B>AVAX TECHNOLOGIES, INC.  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>(Exact Name of Registrant in Its Charter) </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE WIDTH="51%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="44%" ALIGN="CENTER"><FONT SIZE=2><B>Delaware</B></FONT></TD>
<TD WIDTH="23%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="33%" ALIGN="CENTER"><FONT SIZE=2><B>13-3575874</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="44%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>(State or other jurisdiction of</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="33%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>(I.R.S. Employer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="44%" ALIGN="CENTER"><FONT SIZE=2>incorporation or organization)</FONT></TD>
<TD WIDTH="23%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="33%" ALIGN="CENTER"><FONT SIZE=2>Identification Number)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<P ALIGN="CENTER"><FONT SIZE=2><B>4520 Main Street, Suite&nbsp;930, Kansas City, MO 64111  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>(Address of Principal Executive Offices) (Zip Code) </FONT></P>

<HR NOSHADE WIDTH="120">
<P ALIGN="CENTER"><FONT SIZE=2><B>AVAX TECHNOLOGIES, INC.<BR>
AMENDED AND RESTATED 1992 STOCK OPTION PLAN<BR>  </B></FONT><FONT SIZE=2>(Full title of the plan) </FONT></P>

<HR NOSHADE WIDTH="120">
<P ALIGN="CENTER"><FONT SIZE=2><B>Jeffrey M. Jonas, M.D.<BR>
Chief Executive Officer and President<BR>
Avax Technologies,&nbsp;Inc.<BR>
4520 Main Street, Suite&nbsp;930, Kansas City, MO 64111<BR>
(Name and address of agent for service)<BR>
(816) 960-1333<BR>  </B></FONT><FONT SIZE=2>(Telephone number, including area code, of agent for service) </FONT></P>

<HR NOSHADE WIDTH="120">
<P ALIGN="CENTER"><FONT SIZE=2><B>CALCULATION OF REGISTRATION FEE  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="83%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="100%" COLSPAN=9><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TH WIDTH="30%" ALIGN="CENTER"><FONT SIZE=1><B>Title of Securities<BR>
to be Registered</B></FONT><BR></TH>
<TH WIDTH="1%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="19%" ALIGN="CENTER"><FONT SIZE=1><B>Amount<BR>
to be Registered(1)</B></FONT><BR></TH>
<TH WIDTH="1%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="15%" ALIGN="CENTER"><FONT SIZE=1><B>Proposed Maximum<BR>
Offering Price<BR>
Per Unit(2)</B></FONT><BR></TH>
<TH WIDTH="1%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="18%" ALIGN="CENTER"><FONT SIZE=1><B>Proposed Maximum<BR>
Aggregate<BR>
Offering Price(2)</B></FONT><BR></TH>
<TH WIDTH="1%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="15%" ALIGN="CENTER"><FONT SIZE=1><B>Amount of<BR>
Registration Fee</B></FONT><BR></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="100%" COLSPAN=9><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="30%"><FONT SIZE=2>Options to Purchase<BR>
Common Stock</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER"><FONT SIZE=2>4,034,802 shares</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="100%" COLSPAN=9><HR NOSHADE></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="30%"><FONT SIZE=2>Common Stock</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER"><FONT SIZE=2>4,034,802 shares</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>$9.938</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2>$40,097,862.28</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>$10,585.84</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="100%" COLSPAN=9><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<DL compact>
<DT><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>This
registration statement also covers any additional shares of common stock issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction
that occurs without the receipt of consideration and that increases the number of our outstanding shares of common stock.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>Estimated
for the purposes of calculating the registration fee pursuant to Rule&nbsp;457(h)&nbsp;under the Securities Act of 1933, and based on the average of the high and low
prices of our common stock reported on the Nasdaq SmallCap Market on July&nbsp;28, 2000. </FONT></DD></DL>
<HR NOSHADE>
<HR NOSHADE>
<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=631121,FOLIO='blank',FILE='DISK023:[00CHI1.00CHI3651]BA3651A.;12',USER='SBROWN',CD=';1-AUG-2000;06:36' -->
<!-- Generated by Merrill Corporation (www.merrillcorp.com) -->
<H2><FONT SIZE=2> </FONT></H2>
<BR>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ja3651_explanatory_notes"> </A></FONT> <FONT SIZE=2><B>EXPLANATORY NOTES         </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Of the 4,034,802 shares of common stock (and related options) being registered pursuant to this Registration Statement, 2,500,000 shares are issuable upon the
exercise of options under the Company's Amended and Restated 1992 Stock Option Plan (the "Plan"). Of the 2,500,000 shares, 1,618,772 shares relate to options that have been granted under the Plan, but
not exercised, and 881,228 shares relate to options available for future grants under the Plan. Of the remaining 1,534,802 shares being registered pursuant to this Registration Statement, an aggregate
of 242,430 shares relate to options that have been granted to the Company's directors under the Company's director plan, 300,000 shares relate to options that are reasonably expected to be granted to
directors within the next two years under the director plan, which qualifies as an "employee benefit plan" as defined in Rule&nbsp;405 of Regulation C (&sect; 230.405), and an aggregate of
992,372 shares relate to options that have been granted to key employees and consultants of the Company, in each case, under individual compensation agreements with the optionee. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>AS PERMITTED BY THE RULES OF THE SECURITIES AND EXCHANGE COMMISSION, THIS REGISTRATION STATEMENT OMITS THE INFORMATION SPECIFIED IN PART I OF
FORM&nbsp;S-8.</B></FONT></P>

<BR>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ja3651_part_ii_information_req__ja302473"> </A></FONT> <FONT SIZE=2><B>Part II<BR>       INFORMATION REQUIRED IN THE REGISTRATION STATEMENT         </B></FONT></P>

<P><FONT SIZE=2><B>Item 3. Incorporation of Documents by Reference.  </B></FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following documents, all of which have been previously filed by AVAX Technologies,&nbsp;Inc. (the "Company") with the Securities and Exchange Commission
under the Securities Exchange Act of 1934, are incorporated by reference into this Registration Statement: </FONT></P>

<DL compact>
<DT><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2>The
Company's Annual Report on Form 10-KSB for the year ended December&nbsp;31, 1999;
<BR><BR></FONT></DD><DT><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>The
Company's Proxy Statement, as filed with the Securities and Exchange Commission on April&nbsp;28,&nbsp;2000;
<BR><BR></FONT></DD><DT><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>The
Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 2000;
<BR><BR></FONT></DD><DT><FONT SIZE=2>(d)</FONT></DT><DD><FONT SIZE=2>The
description of the Company's common stock contained in the Company's registration statement on Form 8-A; and
<BR><BR></FONT></DD><DT><FONT SIZE=2>(e)</FONT></DT><DD><FONT SIZE=2>The
Company's reports on Form 8-K, as filed with the Securities and Exchange Commission on March&nbsp;23, 2000, and two separate reports on Form 8-K, both filed on July&nbsp;26,
2000. </FONT></DD></DL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All
documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d)&nbsp;of the Securities Exchange Act of 1934, as amended, prior to the filing of a
post-effective amendment that indicates that all securities offered hereunder have been sold or that deregisters all of the securities offered then remaining unsold, shall be deemed to be incorporated
herein by reference and to be a part hereof from the date of filing such documents. </FONT></P>

<P><FONT SIZE=2><B>Item 6. Indemnification of Directors and Officers  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Company was organized under the laws of the State of Delaware, and therefore is subject to Section 145 of the General Corporation Law of the State of
Delaware. Section 145 authorizes a court to award or a corporation's board of directors to grant indemnification to directors and officers in terms broad enough to include indemnification under
certain circumstances for liabilities (including reimbursement for expenses incurred) arising under the Securities Act of 1933, as amended. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>II-1</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=2,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=1020401,FOLIO='II-1',FILE='DISK023:[00CHI1.00CHI3651]JA3651A.;8',USER='SBROWN',CD=';1-AUG-2000;05:28' -->

<P><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;Article&nbsp;Seven of the Company's Certificate of Incorporation provides that the Company will indemnify and advance expenses to its directors and officers to the fullest extent
permitted by Section 145. Article&nbsp;Nine of the Company's Certificate of Incorporation provides that the liability of the Company's directors is eliminated to the fullest extent permitted by
Section 102(b)(7)&nbsp;of the Delaware General Corporation Law. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Article&nbsp;V,
Section 1 of the Company's By-Laws provides for mandatory indemnification of the Company's directors to the fullest extent authorized by the Delaware General
Corporation Law. Article&nbsp;V, Section 2 of the Company's By-Laws provides for prepayment of expenses incurred by its directors to the fullest extent permitted by, and only in compliance with, the
Delaware General Corporate Law. Article&nbsp;V, Section 6 of the Company's By-Laws provides for permissive indemnification of the Company's officers, employees and agents if and to the extent
authorized by its Board of Directors in compliance with the Delaware General Corporation Law. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;These
provisions in the Certificate of Incorporation and the By-Laws do not eliminate the directors' fiduciary duty, and in appropriate circumstances equitable remedies such as
injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director will continue to be subject to liability for breach of the director's duty of
loyalty to us for acts or omissions not in good faith or involving intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the director, and for
payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provisions also do not affect a director's responsibilities under any other law, such as
the federal securities laws or state or federal environmental laws. In addition, the Company has obtained certain liability insurance coverage for its directors and officers. </FONT></P>

<P><FONT SIZE=2><B>Item 8. Exhibits  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="9%" ALIGN="CENTER"><FONT SIZE=1><B>Exhibit No.</B></FONT><HR NOSHADE></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="89%" ALIGN="CENTER"><FONT SIZE=1><B>Description</B></FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Certificate of Incorporation, as amended (excluding the Certificates of Designations for the Series&nbsp;B and Series&nbsp;C Convertible Preferred Stock).<SUP>1</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.2</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>By-Laws.<SUP>2</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.3</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Specimen of Common Stock Certificate.<SUP>2</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.4</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Certificate of Designations of Series&nbsp;C Convertible Preferred Stock.<SUP>3</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>5.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Opinion of Gilmore&nbsp;&amp; Bell, P.C.*</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>23.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Consent of Gilmore&nbsp;&amp; Bell, P.C. Included in Exhibit 5.1.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>23.2</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Consent of Ernst&nbsp;&amp; Young LLP, Independent Auditors.*</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>24.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Power of Attorney (included on the signature page&nbsp;hereof).</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE ALIGN=LEFT WIDTH="120">
<DL compact>
<DT><FONT SIZE=2>*</FONT></DT><DD><FONT SIZE=2>Filed
herewith.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December&nbsp;31, 1999, filed with the Securities and Exchange
Commission on February&nbsp;17, 2000.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>Incorporated
by reference and previously filed as an exhibit to our registration statement on Form SB-2 filed with the Securities and Exchange Commission (File No. 333-09349) on
July&nbsp;31, 1996.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December&nbsp;31, 1998, filed with the Securities and Exchange
Commission on March&nbsp;31, 1999. </FONT></DD></DL>
<P ALIGN="CENTER"><FONT SIZE=2>II-2</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=3,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=981574,FOLIO='II-2',FILE='DISK023:[00CHI1.00CHI3651]JA3651A.;8',USER='SBROWN',CD=';1-AUG-2000;05:28' -->
<UL>
<BR><BR>
</UL>

<P><FONT SIZE=2><B>Item 9. Undertakings  </B></FONT></P>


<P><FONT SIZE=2>The
Company hereby undertakes: </FONT></P>

<UL>
<DL compact>
<DT><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>To
file, during any period in which the Company offers or sells securities, a post-effective amendment to this Registration Statement to include any additional or changed material
information regarding the plan of distribution
<BR><BR></FONT></DD><DT><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>That
for determining liability under the Securities Act of 1933, the Company will treat each post-effective amendment to this Registration Statement and each filing of our annual
report, as a new registration statement of the securities offered, and the offering of the securities at that time will be deemed to be the initial </FONT><FONT SIZE=2><I>bona
fide</I></FONT><FONT SIZE=2> offering.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>To
file a post-effective amendment to remove from registration any of the securities that remain unsold at the end of the offering. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the
Delaware General Corporation Law, the Company's Certificate of Incorporation and its By-Laws, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission
that indemnification is against public policy as expressed in the Securities Act of 1933, and is, therefore, unenforceable. In the event that a claim for indemnification against liabilities arising
under the Securities Act of 1933 (other than the payment by us of expenses incurred or paid by a director, officer, or controlling person of the Company in the successful defense of any action, suit
or proceeding) is asserted by that director, officer or controlling person in connection with the securities that the Company is registering, the Company will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether the indemnification by the Company is against public policy as expressed in the
Securities Act of 1933 and will be governed by the final adjudication of that issue. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>II-3</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=4,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=953300,FOLIO='II-3',FILE='DISK023:[00CHI1.00CHI3651]JA3651A.;8',USER='SBROWN',CD=';1-AUG-2000;05:28' -->
<!-- Generated by Merrill Corporation (www.merrillcorp.com) -->
<H2><FONT SIZE=2> </FONT></H2>
<BR>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="jc3651_signatures"> </A></FONT> <FONT SIZE=2><B>SIGNATURES         </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In accordance with the requirements of the Securities Act of 1933, as amended, the Company certifies that it has reasonable grounds to believe that it will
meet all of the requirements for filing on Form&nbsp;S-8 and has authorized this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of
Kansas City, State of Missouri, on this 31st day of July, 2000. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="48%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="50%" COLSPAN=2><FONT SIZE=2>AVAX TECHNOLOGIES, INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="48%"><FONT SIZE=2>&nbsp;<BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;<BR></FONT> <FONT SIZE=2>By:</FONT></TD>
<TD WIDTH="46%" ALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>JEFFREY M. JONAS, M. D.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Jeffrey M. Jonas, M.D.<BR></FONT> <FONT SIZE=2><I>Chief Executive Officer and President</I></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<BR>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="jc3651_power_of_attorney"> </A></FONT> <FONT SIZE=2><B>POWER OF ATTORNEY         </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We, the undersigned officers and directors of AVAX Technologies,&nbsp;Inc., severally constitute Jeffrey&nbsp;M. Jonas,&nbsp;M.D., or David&nbsp;L.
Tousley, in the order named, our true and lawful attorney-in-fact with full power to each, to sign for us and in our names in the capacities indicated below, this Registration Statement on
Form&nbsp;S-8 and any and all subsequent amendments to this Registration Statement, and generally to do all things in our names and on our behalf in our capacities as officers and directors to
enable AVAX Technologies,&nbsp;Inc. to comply with all requirements of the Securities and Exchange Commission. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates
indicated: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="40%" ALIGN="CENTER"><FONT SIZE=1><B>Signature</B></FONT><HR NOSHADE></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="37%" ALIGN="CENTER"><FONT SIZE=1><B>Name&nbsp;&amp; Title</B></FONT><HR NOSHADE></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="19%" ALIGN="CENTER"><FONT SIZE=1><B>Date</B></FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=1><B>&nbsp;<BR> </B></FONT><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>/s/&nbsp;</FONT><FONT SIZE=2>JEFFREY M. JONAS, M.D.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Jeffrey M. Jonas, M.D.</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>Chief Executive Officer, President and Director</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>DAVID L. TOUSLEY</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> David L. Tousley</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
Chief Financial Officer<BR>
and Secretary<BR>
(Principal Financial and Accounting Officer)</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>JAMES CURRIE</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> James Currie</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
Director</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>ANDREW W. DAHL, SC.D.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Andrew W. Dahl, Sc.D.</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
Director</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>EDISON D. DE CASTRO</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Edison D. de Castro</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
Director</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>GARY S. LAZAR, M.D., F.A.C.P.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Gary S. Lazar, M.D., F.A.C.P.</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
Director</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
<BR></FONT>
</TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- insert table folio -->
<HR NOSHADE>
<!-- ZEQ.=1,SEQ=5,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=254303,FOLIO='blank',FILE='DISK023:[00CHI1.00CHI3651]JC3651A.;15',USER='LCOUTU',CD=';1-AUG-2000;02:00' -->
<!-- end of table folio -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>JOHN K. A. PRENDERGAST, PH.D.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> John K. A. Prendergast, Ph.D.</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
Director</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
/s/&nbsp;</FONT><FONT SIZE=2>CARL SPANA, PH.D.</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Carl Spana, Ph.D.</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
Director</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
July&nbsp;31, 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="40%" ALIGN="CENTER" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="37%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>&nbsp;<BR>&nbsp;</FONT></TD>
<TD WIDTH="19%" VALIGN="CENTER"><FONT SIZE=2>&nbsp;<BR>
&nbsp;<BR>
&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=6,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=846281,FOLIO='blank',FILE='DISK023:[00CHI1.00CHI3651]JC3651A.;15',USER='LCOUTU',CD=';1-AUG-2000;02:00' -->
<!-- Generated by Merrill Corporation (www.merrillcorp.com) -->
<HR NOSHADE>
<HR NOSHADE>
<P ALIGN="CENTER"><FONT SIZE=5><B>SECURITIES AND EXCHANGE COMMISSION  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>Washington, D.C. 20549  </B></FONT></P>

<HR NOSHADE WIDTH="120">
<P ALIGN="CENTER"><FONT SIZE=5><B>EXHIBITS<BR>  </B></FONT><FONT SIZE=2><B>TO  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>REGISTRATION STATEMENT<BR>
ON  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=5><B>FORM S-8  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>UNDER THE SECURITIES ACT OF 1933  </B></FONT></P>

<HR NOSHADE WIDTH="120">
<P ALIGN="CENTER"><FONT SIZE=5><B>AVAX TECHNOLOGIES, INC.  </B></FONT></P>

<HR NOSHADE>
<HR NOSHADE>
<HR NOSHADE>
<!-- ZEQ.=1,SEQ=7,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=847282,FOLIO='blank',FILE='DISK023:[00CHI1.00CHI3651]KA3651A.;10',USER='SBROWN',CD=';1-AUG-2000;06:36' -->
<!-- Generated by Merrill Corporation (www.merrillcorp.com) -->
<H2><FONT SIZE=2> </FONT></H2>
<BR>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kc3651_exhibit_index"> </A></FONT> <FONT SIZE=2><B>EXHIBIT INDEX         </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="9%" ALIGN="CENTER"><FONT SIZE=1><B>Exhibit No.</B></FONT><HR NOSHADE></TH>
<TH WIDTH="2%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="89%" ALIGN="CENTER"><FONT SIZE=1><B>Description</B></FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Certificate of Incorporation, as amended (excluding the Certificates of Designation for the Series&nbsp;B and Series&nbsp;C Convertible Preferred Stock).<SUP>1</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.2</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>By-Laws.<SUP>2</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.3</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Specimen of Common Stock Certificate.<SUP>2</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>4.4</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Certificate of Designations of Series&nbsp;C Convertible Preferred Stock.<SUP>3</SUP></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>5.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Opinion of Gilmore&nbsp;&amp; Bell, P.C.*</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>23.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Consent of Gilmore&nbsp;&amp; Bell, P.C. Included in Exhibit 5.1.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>23.2</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Consent of Ernst&nbsp;&amp; Young LLP, Independent Auditors.*</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="9%" ALIGN="RIGHT"><FONT SIZE=2>24.1</FONT></TD>
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="89%"><FONT SIZE=2>Power of Attorney (included on the signature page&nbsp;hereof).</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE ALIGN=LEFT WIDTH="120">
<DL compact>
<DT><FONT SIZE=2>*</FONT></DT><DD><FONT SIZE=2>Filed
herewith.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December&nbsp;31, 1999, filed with the Securities and Exchange
Commission on February&nbsp;17, 2000.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>Incorporated
by reference and previously filed as an exhibit to our registration statement on Form SB-2 filed with the Securities and Exchange Commission (File No. 333-09349) on
July&nbsp;31, 1996.
<BR><BR></FONT></DD><DT><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December&nbsp;31, 1998, filed with the Securities and Exchange
Commission on March&nbsp;31, 1999. </FONT></DD></DL>
<HR NOSHADE>
<!-- ZEQ.=1,SEQ=8,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1",CHK=951404,FOLIO='blank',FILE='DISK023:[00CHI1.00CHI3651]KC3651A.;4',USER='FLANGST',CD='31-JUL-2000;22:19' -->
<UL>
</UL>
<!-- Generated by Merrill Corporation (www.merrillcorp.com) -->
<BR>
<H2><FONT SIZE=2><A NAME="00CHI3651_1">QuickLinks</A></FONT></H2>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#ja3651_explanatory_notes">EXPLANATORY NOTES</A></FONT><BR>
<FONT SIZE=2><A HREF="#ja3651_part_ii_information_req__ja302473">Part II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</A></FONT><BR>
<!-- TOC_END -->
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#jc3651_signatures">SIGNATURES</A></FONT><BR>
<FONT SIZE=2><A HREF="#jc3651_power_of_attorney">POWER OF ATTORNEY</A></FONT><BR>
<!-- TOC_END -->
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#kc3651_exhibit_index">EXHIBIT INDEX</A></FONT><BR>
<!-- TOC_END -->
<!-- SEQ=,FILE='QUICKLINK',USER=SBROWN,SEQ=,EFW="2021290",CP="AVAX TECHNOLOGIES",DN="1" -->
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "s-8.htm", "description": "S-8", "secsgml_size_bytes": 34628}]
{"company-data": {"conformed-name": "AVAX TECHNOLOGIES INC", "cik": "0001015441", "assigned-sic": "2836", "irs-number": "133575874", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-42710", "film-number": "683199"}, "business-address": {"street1": "4520 MAIN ST", "street2": "STE 930", "city": "KANSAS CITY", "state": "MO", "zip": "64111", "phone": "8169601333"}, "mail-address": {"street1": "4520 MAIN STREET SUITE 930", "city": "KANSAS CITY", "state": "MO", "zip": "64112"}}
Prepared by MERRILL CORPORATION www.edgaradvantage.com
QuickLinks
-- Click here to rapidly navigate through this document
As filed with the Securities and Exchange Commission on July 31, 2000
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AVAX TECHNOLOGIES, INC.
(Exact Name of Registrant in Its Charter)
Delaware
13-3575874
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification Number)
4520 Main Street, Suite 930, Kansas City, MO 64111
(Address of Principal Executive Offices) (Zip Code)
AVAX TECHNOLOGIES, INC.
AMENDED AND RESTATED 1992 STOCK OPTION PLAN
(Full title of the plan)
Jeffrey M. Jonas, M.D.
Chief Executive Officer and President
Avax Technologies, Inc.
4520 Main Street, Suite 930, Kansas City, MO 64111
(Name and address of agent for service)
(816) 960-1333
(Telephone number, including area code, of agent for service)
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered
Amount
to be Registered(1)
Proposed Maximum
Offering Price
Per Unit(2)
Proposed Maximum
Aggregate
Offering Price(2)
Amount of
Registration Fee
Options to Purchase
Common Stock
4,034,802 shares
Common Stock
4,034,802 shares
$9.938
$40,097,862.28
$10,585.84
(1)
This
registration statement also covers any additional shares of common stock issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction
that occurs without the receipt of consideration and that increases the number of our outstanding shares of common stock.
(2)
Estimated
for the purposes of calculating the registration fee pursuant to Rule 457(h) under the Securities Act of 1933, and based on the average of the high and low
prices of our common stock reported on the Nasdaq SmallCap Market on July 28, 2000.
EXPLANATORY NOTES
Of the 4,034,802 shares of common stock (and related options) being registered pursuant to this Registration Statement, 2,500,000 shares are issuable upon the
exercise of options under the Company's Amended and Restated 1992 Stock Option Plan (the "Plan"). Of the 2,500,000 shares, 1,618,772 shares relate to options that have been granted under the Plan, but
not exercised, and 881,228 shares relate to options available for future grants under the Plan. Of the remaining 1,534,802 shares being registered pursuant to this Registration Statement, an aggregate
of 242,430 shares relate to options that have been granted to the Company's directors under the Company's director plan, 300,000 shares relate to options that are reasonably expected to be granted to
directors within the next two years under the director plan, which qualifies as an "employee benefit plan" as defined in Rule 405 of Regulation C (§ 230.405), and an aggregate of
992,372 shares relate to options that have been granted to key employees and consultants of the Company, in each case, under individual compensation agreements with the optionee.
AS PERMITTED BY THE RULES OF THE SECURITIES AND EXCHANGE COMMISSION, THIS REGISTRATION STATEMENT OMITS THE INFORMATION SPECIFIED IN PART I OF
FORM S-8.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, all of which have been previously filed by AVAX Technologies, Inc. (the "Company") with the Securities and Exchange Commission
under the Securities Exchange Act of 1934, are incorporated by reference into this Registration Statement:
(a)
The
Company's Annual Report on Form 10-KSB for the year ended December 31, 1999;
(b)
The
Company's Proxy Statement, as filed with the Securities and Exchange Commission on April 28, 2000;
(c)
The
Company's Quarterly Report on Form 10-QSB for the quarter ended March 31, 2000;
(d)
The
description of the Company's common stock contained in the Company's registration statement on Form 8-A; and
(e)
The
Company's reports on Form 8-K, as filed with the Securities and Exchange Commission on March 23, 2000, and two separate reports on Form 8-K, both filed on July 26,
2000.
All
documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended, prior to the filing of a
post-effective amendment that indicates that all securities offered hereunder have been sold or that deregisters all of the securities offered then remaining unsold, shall be deemed to be incorporated
herein by reference and to be a part hereof from the date of filing such documents.
Item 6. Indemnification of Directors and Officers
The Company was organized under the laws of the State of Delaware, and therefore is subject to Section 145 of the General Corporation Law of the State of
Delaware. Section 145 authorizes a court to award or a corporation's board of directors to grant indemnification to directors and officers in terms broad enough to include indemnification under
certain circumstances for liabilities (including reimbursement for expenses incurred) arising under the Securities Act of 1933, as amended.
II-1
Article Seven of the Company's Certificate of Incorporation provides that the Company will indemnify and advance expenses to its directors and officers to the fullest extent
permitted by Section 145. Article Nine of the Company's Certificate of Incorporation provides that the liability of the Company's directors is eliminated to the fullest extent permitted by
Section 102(b)(7) of the Delaware General Corporation Law.
Article V,
Section 1 of the Company's By-Laws provides for mandatory indemnification of the Company's directors to the fullest extent authorized by the Delaware General
Corporation Law. Article V, Section 2 of the Company's By-Laws provides for prepayment of expenses incurred by its directors to the fullest extent permitted by, and only in compliance with, the
Delaware General Corporate Law. Article V, Section 6 of the Company's By-Laws provides for permissive indemnification of the Company's officers, employees and agents if and to the extent
authorized by its Board of Directors in compliance with the Delaware General Corporation Law.
These
provisions in the Certificate of Incorporation and the By-Laws do not eliminate the directors' fiduciary duty, and in appropriate circumstances equitable remedies such as
injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director will continue to be subject to liability for breach of the director's duty of
loyalty to us for acts or omissions not in good faith or involving intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the director, and for
payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provisions also do not affect a director's responsibilities under any other law, such as
the federal securities laws or state or federal environmental laws. In addition, the Company has obtained certain liability insurance coverage for its directors and officers.
Item 8. Exhibits
Exhibit No.
Description
4.1
Certificate of Incorporation, as amended (excluding the Certificates of Designations for the Series B and Series C Convertible Preferred Stock).
1
4.2
By-Laws.
2
4.3
Specimen of Common Stock Certificate.
2
4.4
Certificate of Designations of Series C Convertible Preferred Stock.
3
5.1
Opinion of Gilmore & Bell, P.C.*
23.1
Consent of Gilmore & Bell, P.C. Included in Exhibit 5.1.
23.2
Consent of Ernst & Young LLP, Independent Auditors.*
24.1
Power of Attorney (included on the signature page hereof).
*
Filed
herewith.
(1)
Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December 31, 1999, filed with the Securities and Exchange
Commission on February 17, 2000.
(2)
Incorporated
by reference and previously filed as an exhibit to our registration statement on Form SB-2 filed with the Securities and Exchange Commission (File No. 333-09349) on
July 31, 1996.
(3)
Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December 31, 1998, filed with the Securities and Exchange
Commission on March 31, 1999.
II-2
Item 9. Undertakings
The
Company hereby undertakes:
(1)
To
file, during any period in which the Company offers or sells securities, a post-effective amendment to this Registration Statement to include any additional or changed material
information regarding the plan of distribution
(2)
That
for determining liability under the Securities Act of 1933, the Company will treat each post-effective amendment to this Registration Statement and each filing of our annual
report, as a new registration statement of the securities offered, and the offering of the securities at that time will be deemed to be the initial
bona
fide
offering.
(3)
To
file a post-effective amendment to remove from registration any of the securities that remain unsold at the end of the offering.
Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the
Delaware General Corporation Law, the Company's Certificate of Incorporation and its By-Laws, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission
that indemnification is against public policy as expressed in the Securities Act of 1933, and is, therefore, unenforceable. In the event that a claim for indemnification against liabilities arising
under the Securities Act of 1933 (other than the payment by us of expenses incurred or paid by a director, officer, or controlling person of the Company in the successful defense of any action, suit
or proceeding) is asserted by that director, officer or controlling person in connection with the securities that the Company is registering, the Company will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether the indemnification by the Company is against public policy as expressed in the
Securities Act of 1933 and will be governed by the final adjudication of that issue.
II-3
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, as amended, the Company certifies that it has reasonable grounds to believe that it will
meet all of the requirements for filing on Form S-8 and has authorized this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of
Kansas City, State of Missouri, on this 31st day of July, 2000.
AVAX TECHNOLOGIES, INC.
By:
/s/
JEFFREY M. JONAS, M. D.
Jeffrey M. Jonas, M.D.
Chief Executive Officer and President
POWER OF ATTORNEY
We, the undersigned officers and directors of AVAX Technologies, Inc., severally constitute Jeffrey M. Jonas, M.D., or David L.
Tousley, in the order named, our true and lawful attorney-in-fact with full power to each, to sign for us and in our names in the capacities indicated below, this Registration Statement on
Form S-8 and any and all subsequent amendments to this Registration Statement, and generally to do all things in our names and on our behalf in our capacities as officers and directors to
enable AVAX Technologies, Inc. to comply with all requirements of the Securities and Exchange Commission.
In
accordance with the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates
indicated:
Signature
Name & Title
Date
/s/
JEFFREY M. JONAS, M.D.
Jeffrey M. Jonas, M.D.
Chief Executive Officer, President and Director
July 31, 2000
/s/
DAVID L. TOUSLEY
David L. Tousley
Chief Financial Officer
and Secretary
(Principal Financial and Accounting Officer)
July 31, 2000
/s/
JAMES CURRIE
James Currie
Director
July 31, 2000
/s/
ANDREW W. DAHL, SC.D.
Andrew W. Dahl, Sc.D.
Director
July 31, 2000
/s/
EDISON D. DE CASTRO
Edison D. de Castro
Director
July 31, 2000
/s/
GARY S. LAZAR, M.D., F.A.C.P.
Gary S. Lazar, M.D., F.A.C.P.
Director
July 31, 2000
/s/
JOHN K. A. PRENDERGAST, PH.D.
John K. A. Prendergast, Ph.D.
Director
July 31, 2000
/s/
CARL SPANA, PH.D.
Carl Spana, Ph.D.
Director
July 31, 2000
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
EXHIBITS
TO
REGISTRATION STATEMENT
ON
FORM S-8
UNDER THE SECURITIES ACT OF 1933
AVAX TECHNOLOGIES, INC.
EXHIBIT INDEX
Exhibit No.
Description
4.1
Certificate of Incorporation, as amended (excluding the Certificates of Designation for the Series B and Series C Convertible Preferred Stock).
1
4.2
By-Laws.
2
4.3
Specimen of Common Stock Certificate.
2
4.4
Certificate of Designations of Series C Convertible Preferred Stock.
3
5.1
Opinion of Gilmore & Bell, P.C.*
23.1
Consent of Gilmore & Bell, P.C. Included in Exhibit 5.1.
23.2
Consent of Ernst & Young LLP, Independent Auditors.*
24.1
Power of Attorney (included on the signature page hereof).
*
Filed
herewith.
(1)
Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December 31, 1999, filed with the Securities and Exchange
Commission on February 17, 2000.
(2)
Incorporated
by reference and previously filed as an exhibit to our registration statement on Form SB-2 filed with the Securities and Exchange Commission (File No. 333-09349) on
July 31, 1996.
(3)
Incorporated
by reference and previously filed as an exhibit to our Annual Report on Form 10-KSB for the year ended December 31, 1998, filed with the Securities and Exchange
Commission on March 31, 1999.
QuickLinks
EXPLANATORY NOTES
Part II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
SIGNATURES
POWER OF ATTORNEY
EXHIBIT INDEX